Application of COP vial in cell and gene therapy drugs

With the rapid development of life sciences and medicine, cell and gene therapy drugs have made many breakthroughs in the prevention and treatment of tumors, damage repair, chronic diseases, single-gene genetic diseases and other medical problems, and have become the key support and development direction of the medical field. While the field of cell and gene therapy drugs is rapidly developing, COP vial have also played an important role.

RTU(ready to use) 2ml COP vial

5ml COP vial

100ml COP injection vial

Cell and gene therapy drugs are the third generation of drugs after small molecular drugs and macromolecular biological products, including cell therapy and gene therapy (and genetically modified cell drugs). Gene therapy, the technique of modifying a person's genes to treat or cure disease, is a revolutionary advance in the life sciences. It uses corresponding means to correct gene mutations that induce disease, add therapeutic genes to specific sites in the genome, and knock out disease-causing genes or genome sequences to achieve the desired therapeutic effect on the disease.

The definition of cell therapy is to provide healthy living cells to the patient to repair or replace the patient's damaged cells or tissues. The emergence of these two treatment methods has provided new ideas and new methods for the treatment of more diseases. In the new era of gene and cell therapy development, the organic combination of the two will surely promote the development of gene therapy and cell therapy, provide the possibility of curing more diseases, and bring dawn to the biomedical industry. Most cell gene therapy drugs have protein properties, and ordinary glass bottles cannot meet their storage requirements. In the selection of packaging, COP vial with low protein adsorption performance are generally used. storage requirements. Domestic pharmaceutical packaging material companies have already mastered the production technology of COP vial, which has injected new impetus into the development of this industry.

In addition, the country also supports cell and gene therapy. In September 2019, the official website of the Ministry of Science and Technology released the "2020 Annual Project Application Guidelines for the "Stem Cell and Transformation Research" Pilot Project (Draft for Comment)", which clearly stated: The total cost is 230 million yuan. Tianjin, Xiongan New Area, Hainan and other places have also released policies to support the development of cell industry technology. With the in-depth development of cell and gene therapy, COP vial will also play a more important role in it.

Note: Part of the content comes from the public account bioSeedin, which was invaded and deleted.